Nasopharyngeal Cancer Market - Segments, Dynamics, Size and Forecast (2016 - 2022)

Submitted by: Submitted by

Views: 10

Words: 983

Pages: 4

Category: Business and Industry

Date Submitted: 03/17/2016 03:40 AM

Report This Essay

Nasopharyngeal Cancer Market - Segments, Dynamics,

Size and Forecast (2016 - 2022)

Persistence Market Research

Nasopharyngeal Cancer Market - Segments,

Dynamics, Size and Forecast (2016 - 2022)

Persistence Market Research

1

Nasopharyngeal Cancer Market - Segments, Dynamics,

Size and Forecast (2016 - 2022)

Persistence Market Research Released New Market Report on “Nasopharyngeal Cancer

Market - Segments, Dynamics, Size and Forecast (2016 - 2022)”.

Nasopharyngeal is a type of cancer which takes place in head or neck. It happens in

nasopharynx, which is a upper part of the of the throat behind the nose. It is also called

nasopharyngeal carcinoma (NPC). It has also been linked with Epstein-Barr virus.

In 2015, American Society of Clinical Oncology (ASCO) estimated 3200 to be diagnosed with

NPC in U.S. The prevalence rate is fairly rate, as one in out of every 100,000 population are

diagnosed with this chronic disorder. However, over the last few years, there has been a

dramatic rise in prevalence rate of nasopharyngeal cancer. This is mainly attributed to

increasing tobacco and alcohol consumption. The global prevalence of nasopharyngeal cancer

is likely to peak by the end of forecast period. In developing region, nasopharyngeal cancer is

widely prevalent in South East Asia such as China. Various symptoms of nasopharyngeal

cancer are lump in the neck, hearing loss, stuffiness, numbness, frequent headaches, fatigue,

blurred, weight loss etc.

Increasing geriatric population, rise in consumption of tobacco, increasing health awareness,

changing lifestyle, are key driving factors for nasopharyngeal cancer treatment market. Also,

rapid adoption of technologies in healthcare premises is expected to further boost

nasopharyngeal cancer treatment market. This trend is likely to be seen in developing regions

where healthcare expenditure is increasing at a significant rate. Developed regions are

witnessing since accessibility for nasopharyngeal cancer treatment and...